|
C6ORF120 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.08379999974595E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.67550001545425E-09 |
| Normal-vs-Stage2 |
2.259400E-01 |
| Normal-vs-Stage3 |
1.547190E-01 |
| Normal-vs-Stage4 |
8.843600E-02 |
| Stage1-vs-Stage2 |
3.872100E-02 |
| Stage1-vs-Stage3 |
2.092000E-02 |
| Stage1-vs-Stage4 |
4.703800E-01 |
| Stage2-vs-Stage3 |
9.856800E-01 |
| Stage2-vs-Stage4 |
5.453600E-01 |
| Stage3-vs-Stage4 |
5.376600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.30459999867239E-08 |
| Normal-vs-AfricanAmerican |
4.813300E-04 |
| Normal-vs-Asian |
4.320100E-03 |
| Caucasian-vs-AfricanAmerican |
4.044600E-01 |
| Caucasian-vs-Asian |
8.372400E-01 |
| AfricanAmerican-vs-Asian |
6.486600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.27349999621418E-09 |
| Normal-vs-Female |
7.918600E-03 |
| Male-vs-Female |
2.230400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.241870E-03 |
| Normal-vs-Extreme_Weight |
1.66220037733922E-10 |
| Normal-vs-Obese |
3.638900E-03 |
| Normal-vs-Extreme_Obese |
3.419200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.597830E-01 |
| Normal_Weight-vs-Obese |
4.364400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.723000E-01 |
| Extreme_Weight-vs-Obese |
7.077200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.677760E-01 |
| Obese-vs-Extreme_Obese |
7.474400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.087830E-01 |
| Normal-vs-Age(41-60Yrs) |
1.563280E-04 |
| Normal-vs-Age(61-80Yrs) |
5.076799980408E-09 |
| Normal-vs-Age(81-100Yrs) |
1.73479999999726E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.347200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.292000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.046200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.972180E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.124970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.152000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.85019996282676E-09 |
| Normal-VS-Type2 PRCC |
1.116300E-03 |
| Normal-VS-KIRP CIMP |
8.047600E-01 |
| Normal-VS-Unclassified PRCC |
1.701720E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.374500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.619600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.888400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.365800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.398400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.173600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.78670000000292E-05 |
| Normal-vs-N1 |
2.073000E-01 |
| Normal-vs-N2 |
3.67540000000277E-05 |
| N0-vs-N1 |
1.143030E-01 |
| N0-vs-N2 |
2.670400E-01 |
| N1-vs-N2 |
7.416100E-02 |
|
|
